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BACKGROUND AND PURPOSE
Conventional determination of agonist efﬁcacy at G-protein coupled receptors is measured by stimulation of
guanosine-5′-g-thiotriphosphate (GTPgS) binding. We analysed the role of guanosine diphosphate (GDP) in the process of
activation of the M2 muscarinic acetylcholine receptor and provide evidence that negative cooperativity between agonist and
GDP binding is an alternative measure of agonist efﬁcacy.
EXPERIMENTAL APPROACH
Filtration and scintillation proximity assays measured equilibrium binding as well as binding kinetics of [35S]GTPgS and
[3H]GDP to a mixture of G-proteins as well as individual classes of G-proteins upon binding of structurally different agonists to
the M2 muscarinic acetylcholine receptor.
KEY RESULTS
Agonists displayed biphasic competition curves with the antagonist [3H]-N-methylscopolamine. GTPgS( 1mM) changed the
competition curves to monophasic with low afﬁnity and 50 mM GDP produced a similar effect. Depletion of membrane-bound
GDP increased the proportion of agonist high-afﬁnity sites. Carbachol accelerated the dissociation of [3H]GDP from
membranes. The inverse agonist N-methylscopolamine slowed GDP dissociation and GTPgS binding without changing afﬁnity
for GDP. Carbachol affected both GDP association with and dissociation from Gi/o G-proteins but only its dissociation from
Gs/olf G-proteins.
CONCLUSIONS AND IMPLICATIONS
These ﬁndings suggest the existence of a low-afﬁnity agonist-receptor conformation complexed with GDP-liganded G-protein.
Also the negative cooperativity between GDP and agonist binding at the receptor/G-protein complex determines agonist
efﬁcacy. GDP binding reveals differences in action of agonists versus inverse agonists as well as differences in activation of Gi/o
versus Gs/olf G-proteins that are not identiﬁed by conventional GTPgS binding.
Abbreviations
CHO cells, Chinese hamster ovary cells; GDP, guanosine diphosphate; GTPgS, guanosine-5′-g-thiotriphosphate; NMS,
N-methylscopolamine
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Almost 900 genes of the human genome encode several thou-
sands of G-protein coupled receptors (GPCRs). GPCRs thus
represent the largest family of receptors. The heterotrimeric
guanine nucleotide-binding proteins (G-proteins) function to
transduce signals from these receptors to effector systems
including enzymes, such as adenylyl cyclase and phospholi-
pase C and ion channels. Binding of an agonist to a GPCR
induces conformational changes in the receptor protein that
enable the receptor to promote guanosine diphosphate (GDP)
release from the a-subunit of interacting heterotrimeric
G-proteins (Ga) (Wess, 1997) and formation of a high-afﬁnity
complex with guanine nucleotide-free Ga (Kent et al., 1980).
The Ga subunit dissociates from the agonist-receptor-Ga
complex upon binding of GTP and releases free Ga with
bound GTP and bg dimer, both of which are involved in
regulation of the activity of various effector systems.
The biological activity of an agonist is a product of both
afﬁnity and efﬁcacy. While afﬁnity of an agonist for a receptor
is strictly given by free binding energy, agonist efﬁcacy in
transducing a signal across the cell membrane depends on
time-ordered complex conformational changes involving
interactions among agonist, receptor, G-protein and guanine
nucleotides. These interactions and the resulting conforma-
tional changes are less well characterized. In their pioneering
work, De Lean et al. (1980) reported that GDP did not affect
the efﬁcacy of b-adrenoceptor agonists at Gs G-protein-
coupled receptors. However, it has been repeatedly demon-
strated that GDP affects binding of agonists at Gi G-protein
coupled GPCRs (Florio and Sternweis, 1989; Tota and Schi-
merlik, 1990), muscarinic agonists decrease GDP binding
(Haga et al., 1986; Shiozaki and Haga, 1992) and accelerate its
dissociation (Ferguson et al., 1986). Although the structural
basis for many steps in the G-protein nucleotide cycle have
been clariﬁed over the past decade, the precise mechanism for
receptor-mediated G-protein activation (GDP-GTP exchange)
remains incompletely deﬁned largely because of difﬁculties in
obtaining crystals of receptor G-protein complexes for X-ray
diffraction analysis (Johnston and Siderovski, 2007; Oldham
and Hamm, 2008).
The aim of our study was to investigate in detail the
mechanisms that determine efﬁcacy of agonists at individual
classes of G-proteins coupled to M2 muscarinic acetylcholine
receptors in natural membrane environments. We performed
detailed analyses of allosteric interactions between guanine
nucleotides and four structurally distinct agonists exhibiting
different potencies and efﬁcacies at the M2 receptor expressed
in Chinese hamster ovary (CHO) cells. We showed that the
efﬁcacy of these agonists in stimulation of GTP binding cor-
relates with the magnitude of negative cooperativity with
GDP binding to the receptor G-protein complex. These data
suggest that the decrease in GDP afﬁnity due to acceleration
of its dissociation plays a key role in determining agonist
efﬁcacy at the muscarinic M2 receptor. We suggest that mea-
surements of GDP binding provide additional information on
receptor activation to that obtained from GTP binding assays.
Most importantly, it reveals differences in the action of ago-
nists and inverse agonists that are not observable in GTP
binding studies.
Methods
Cell culture and membrane preparation
Chinese hamster ovary cells stably transfected with the
human M2 muscarinic receptor gene (CHO-M2 cells) were
kindly donated by Professor T.I.Bonner. Cell cultures and
crude membranes were prepared as described previously
(Jakubík et al., 2006). Brieﬂy, cells were grown to conﬂuency
in 75 cm
2 ﬂasks in Dulbecco’s modiﬁed Eagle’s medium
supplemented with 10% fetal bovine serum and 2 ¥ 10
6 cells
were subcultured to 100 mm Petri dishes. Medium was
supplemented with 5 mM butyrate for the last 24 h of culti-
vation to increase receptor expression. Cells were detached by
mild trypsinization on day 5 after subculture. Detached cells
were washed twice in 50 mL of phosphate-buffered saline and
3 min centrifugation at 250¥ g. Washed cells were suspended
in 20 mL of ice-cold incubation medium (100 mM NaCl,
20 mM Na-HEPES, 10 mM MgCl2;p H= 7.4) supplemented
with 10 mM EDTA and homogenized on ice by two 30 s
strokes using Polytron homogenizer (Ultra-Turrax; Janke &
Kunkel GmbH & Co. KG, IKA-Labortechnik, Staufen,
Germany) with a 30 s pause between strokes. Cell homoge-
nates were centrifuged for 30 min at 30 000¥ g. Supernatants
were discarded, pellets resuspended in fresh incubation
medium and centrifuged again. Resulting membrane pellets
were kept at -20°C until assayed within a maximum of 10
weeks.
Preparation of GDP-less membranes
Membrane-bound GDP was removed by mild denaturation
(Ferguson et al., 1986). Membranes were incubated for 3 h in
1 M ammonium sulphate at 4°C, centrifuged and resus-
pended in incubation medium containing 20% glycerol
for 1 h to allow renaturation. Then they were again centri-
fuged, resuspended in incubation medium, and used for
experiments.
Equilibrium radioligand binding experiments
All radioligand binding experiments were optimized and
carried out as described earlier (Jakubík et al., 2006). Brieﬂy,
membranes were incubated in 96-well plates at 30°C in the
incubation medium described above that was supplemented
with freshly prepared dithiotreitol at a ﬁnal concentration of
1 mM. Incubation volume was 200 mLo r8 0 0mL for [
3H]N-
methylscopolamine (NMS) saturation experiments. Approxi-
mately 30 and 10 mg of membrane proteins per sample were
used for [
3H]NMS and [
35S]GTPgS binding respectively. NMS
binding was measured directly in saturation experiments
using six concentrations (30 pM to 1000 pM) of [
3H]NMS for
1 h. Depletion of radioligand was smaller than 20% for the
lowest concentration. For calculations, radioligand concen-
trations were corrected for depletion. Agonist binding was
determined in competition experiments with 1 nM [
3H]NMS.
Membranes were ﬁrst pre-incubated 60 min with agonists
and guanine nucleotides, if applicable, and then incubated
with [
3H]NMS for additional 120 min. Non-speciﬁc binding
was determined in the presence of 10 mM NMS. Equilibrium
[3H]GDP binding was measured after 5 h incubation. Non-
speciﬁc binding was determined in the presence of 50 mM
GDP. Agonist stimulated [
35S]GTPgS binding was measured in
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of [
35S]GTPgS and 50 mM GDP for 20 min at 30°C after 60 min
pre-incubation with GDP and agonist. Non-speciﬁc binding
was determined in the presence of 1 mM unlabelled GTPgS.
Incubations were terminated by ﬁltration through Whatman
GF/F glass ﬁbre ﬁlters (Whatman, Maidstone, UK) using a
Tomtech Mach III cell harvester (Perkin Elmer, Norwalk, CT,
USA). Filters were dried in vacuum for 1 h at 80°C and then
solid scintillator Meltilex A was melted on ﬁlters (105°C, 90 s)
using a hot plate. The ﬁlters were cooled and counted in
Wallac Microbeta scintillation counter.
Kinetic experiments
Kinetics of [
35S]GTPgS binding at GDP-less membranes was
measured in a ﬁnal volume of 200 mL at 30°C. Association of
1n M [
35S]GTPgS with GDP-less membranes was measured
after 20 min pre-incubation with buffer or carbachol  50 mM
GDP. Dissociation of [
35S]GTPgS was initiated by 1 mM GTPgS
alone or in mixture with carbachol after 90 min pre-
incubation of GDP-less membranes with 1 nM [
35S]GTPgS 
50 mM GDP. Kinetics of [
3H]GDP binding at Gi/o and Gs/olf
G-proteins was measured using scintillation proximity assay
(SPA) (DeLapp et al., 1999) essentially as described earlier
(Jakubík et al., 2006). Association of 500 nM [
3H]GDP was
measured after 20 min pre-incubation of GDP-less mem-
branes with buffer or carbachol. Dissociation of [
3H]GDP was
started by addition of 50 mM GDP alone or in mixture with
carbachol after prelabelling GDP-less membranes with
500 nM [
3H]GDP for 180 min at 30°C. Dissociation was
stopped by cooling and solubilization of samples by adding
Nonidet P-40 to ﬁnal concentration of 1% for 15 min.
Primary polyclonal rabbit IgG antibody against a subunit of
Gi/o or Gs/olf G-proteins in ﬁnal dilution 1:1000 was then
added and samples were incubated on ice for 60 min. After-
wards, 50 mL aliquots of anti-rabbit IgG coated scintillation
beads were added (Amersham Bioscience, Buckinghamshire,
UK; 500 mg of beads was resuspended in 40 mL of incubation
buffer) and incubation continued for another 3 h. Trapped a
subunits were pelleted at 4°C and 1500¥ g for 15 min and
counted using SPA protocol in Wallac Microbeta scintillation
counter.
Data analysis
In general binding data were analysed as described previously
(Jakubík et al., 2006). Data were preprocessed by Open Ofﬁce
2.3 (http://www.openofﬁce.org) and subsequently analysed
by Grace 5.1.18 (http://plasma-gate.weizman.ac.il/Grace) and
statistic package R (http://www.r-project.org) on Mandriva
distribution of Linux.
The following equations were ﬁtted to data:
Saturation of radioligand binding
yx x =× + BK MAX D /( ) (Eqn 1)
y, binding of radioligand at free concentration of radioligand
x;B MAX, maximum binding capacity; KD, equilibrium dissocia-
tion constant.
Concentration–response
yx =+ − + 11 1 50 () / ( ( ) EE C / ) MAX
nH (Eqn 2)
y, radioactivity in the presence of agonist at concentration x
normalized to radioactivity in the absence of agonist; EMAX,
maximal increase by agonist; EC50, concentration of agonist
producing 50% of maximal effect; nH, Hill coefﬁcient.
Interference with [
3H]NMS or [
3H]GDP binding
yx x =× − + 100 1 50 (/ ( ) )
nH nH IC (Eqn 3)
yx x x x = − ×− + + ×− + () ( / ( ) ) ( / ( ) ) 100 1 1 50 50 fI C f I C low high low low
(Eqn 4)
y, binding of radioligand at a concentration of displacer x
normalized to binding in the absence of displacer; IC50,
concentration causing 50% decrease in binding; nH, Hill
coefﬁciet; flow, percentage of low afﬁnity sites; IC50high, concen-
tration causing 50% decrease in binding to high afﬁnity sites;
IC50low, concentration causing 50% decrease in binding to low
afﬁnity sites. Both equations were ﬁtted to data and the one
giving better ﬁt determined by F-test was used. Equilibrium
dissociation constant of displacer (KI) was calculated accord-
ing to Cheng and Prusoff (Cheng and Prusoff, 1973).
Rate of association
yx =× − − ×× Bk eq obs [e x p ( ) ] 11 (Eqn 5a)
yx x =× −− ×× +× −− ×× Bk Bk eq obs eq obs 11 22 11 11 (e x p ( ) ) [e x p ( ) ]
(Eqn 5b)
y, binding of radioligand at time x;k obs,k obs1,k obs2, observed
rates of association; Beq,B eq1,B eq2, equilibrium binding.
Rate of radioligand dissociation
y
x =×
−× 100 e
koff () (Eqn 6a)
y
xx =− × + ×
−× −× ()
() () 100 2
1
2
2 fe f e
koff koff (Eqn 6b)
y, binding of radioligand at time x normalized to time 0; koff,
koff1,k off2, rate constants; f2, percentage of sites with rate con-
stant koff2.
Allosteric interaction of radioligand
Allosteric interaction between a radioligand and an allosteric
modulator was analysed according to the ternary complex
model (Ehlert, 1988).
y
DK
D
KK x
Kx
D
DA
A
=
+
+
×+
+
[]
[]
()
/α
(Eqn 7)
y, binding of radioligand in the presence of ligand A at con-
centration x normalized to the absence of ligand A; [D] con-
centration of radioligand; KD, equilibrium dissociation
constant of radioligand; KA; equilibrium dissociation con-
stant of ligand A; a, factor of cooperativity between radioli-
gand and ligand A.
Allosteric interaction between GDP and
agonist binding
Allosteric interaction between GDP and agonist binding was
analysed according to the ternary complex model with ago-
nists competing with radioligand (Jakubík et al., 1997).
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=
+
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×+
[]
[]
([ ] ( / ) ( ))
(/ )
β
α
(Eqn 8)
y, binding of radioligand ([
3H]NMS) in the presence of GDP at
concentration x normalized to the absence of GDP; [D] con-
centration of radioligand; KD, equilibrium dissociation con-
stant of radioligand; [A], concentration of agonist; KI,
equilibrium dissociation constant of high afﬁnity agonist
binding form Eqn 3; KA, equilibrium dissociation constant of
allosteric ligand (GDP); a, factor of cooperativity between
radioligand and allosteric ligand from Eqn 7 (always 1); b,
factor of cooperativity between allosteric ligand and agonist.
Materials
The radioligands [
3H]NMS ([
3H]GDP), [
35S]GTPgS and anti-
rabbit IgG-coated scintillation proximity beads were from
Amersham (UK). Rabbit polyclonal antibodies against
C-terminus of G-protein (Gi/o, C-10, and Gs/olf, C-18) were
from Santa Cruz Biotechnology (Santa Cruz, CA, USA) Car-
bachol, dithiotreitol, EDTA, GDP, GTPgS, NMS chloride and
pilocarpine were from Sigma (St. Louis, MO, USA). Oxotremo-
rine was from RBI (Natick, MA, USA) and Nonidet P-40 was
from USB Corporation (Cleveland, OH, USA). Furmethide
was kindly donated by Dr Shelkovnikov (University of
St. Petersburg, Russia). Nomenclature of receptors and
G-proteins follows Alexander et al. (2009).
Results
General characterization of crude membranes
Experiments were performed on membranes of CHO-M2 cells
stably expressing 1.4  0.2 pmol of binding sites for [
3H]NMS
chloride per mg of membrane protein. The equilibrium dis-
sociation constant (KD)o f[
3H]NMS was 512  32 pM (mean
 SEM, n = 4, measurements on cells from independent
seedings). Total binding of [
35S]GTPgS to crude membranes
was 123  18 pmol per mg of protein out of which 74 
11 pmol was to Gi/o,2 1 3 pmol to Gq/11 and 16  3 pmol to
Gs/olf G-proteins respectively (means  SEM, n = 3).
Carbachol, furmethide, oxotremorine and pilocarpine
concentration dependently stimulated binding of [
35S]GTPgS
(Figure 1, Table 1). Carbachol and furmethide induced similar
maximal increase of [
35S]GTPgS binding (threefold and 3.1-
fold increase respectively) with half-effective concentrations
(EC50) of 12.3 and 7.0 mM respectively. Oxotremorine and
pilocarpine were more potent (EC50 = 1.0 and 1.2 mM respec-
tively) but less efﬁcacious (Emax = 2.8 and 1.6-fold increase
respectively). The rank order of efﬁcacy was: furmethide =
carbachol > oxotremorine > pilocarpine, with a ranking of
potency of: oxotremorine = pilocarpine > furmethide = car-
bachol. Carbachol had no effect on [
35S]GTPgS binding at
wild-type (non-transfected) CHO cells.
Inﬂuence of guanine nucleotides on the
afﬁnity of agonists
Afﬁnity of agonist binding was assessed indirectly in compe-
tition experiments with 1 nM of the muscarinic radioligand
[
3H]NMS (Figure 2). Competition curves were biphasic and
displayed a similar proportion (50 to 66%) of low-afﬁnity
binding sites for all agonists but different afﬁnities for both
high- and low-afﬁnity binding sites (Table 2). High-afﬁnity
binding ranged from 12 nM for oxotremorine to 120 nM for
carbachol and low-afﬁnity binding from 580 nM for
oxotremorine to 9 mM for carbachol. Competition curves
between [
3H]NMS and agonists in the presence of 1 mM GTPgS
expectedly became monophasic for all agonists (Figure 2)
with calculated equilibrium inhibition constants (KI) corre-
sponding to the low-afﬁnity KI in the absence of GTPgS.
Similarly, 50 mM GDP present during competition measure-
ments (Figure 2) also converted curves to monophasic ones
with KI corresponding to that in the presence of GTPgS and
the low-afﬁnity KI in the absence of added nucleotides
(Figure 2, Table 2).
In order to explore the effects of added GDP on agonist
binding, we reduced membrane-bound native GDP by induc-
ing its dissociation under slightly denaturing conditions,
washing and renaturing as described in Methods. Competition
curves remained biphasic (Figure 2) but the proportion of
low-afﬁnity sites decreased ﬁvefold to sevenfold compared
with membranes before treatment (Table 2). Low-afﬁnity KI of
agonists corresponded to the low-afﬁnity KI under control
conditions. High-afﬁnity KI values were signiﬁcantly lower
for carbachol and oxotremorine (twofold and fourfold respec-
tively) and not changed for oxotremorine and pilocarpine.
Characterization of GDP-depleted membranes
In comparison with crude membranes, depletion of GDP did
not change the afﬁnity for [
3H]NMS (498  29 pM) but
increased the number of binding sites per mg of protein to 24
 3 pmol (mean  SEM, n = 4). On the other hand, total
binding of [
35S]GTPgS per mg of protein fell to 28  2 pmol
-10 -9 -8 -7 -6 -5 -4 -3
agonist [log c]
0
0.5
1
1.5
2
2.5
3
3.5
[
3
5
S
]
G
T
P
γ
S
 
b
i
n
d
i
n
g
 
[
f
o
l
d
 
o
v
e
r
 
b
a
s
a
l
]
carbachol
furmethide
oxotremorine
pilocarpine
NMS
Figure 1
Stimulation of [
35S]guanosine-5′-g-thiotriphosphate (GTPgS) binding
by agonists. [
35S]GTPgS binding to membranes stimulated by
increasing concentrations (abscissa, log M) of agonists carbachol,
furmethide, oxotremorine, pilocarpine and antagonist N-
methylscopolamine (NMS) is expressed as fold over basal (ordinate).
Data are mean  SEM of values from three experiments performed
in quadruplicate. Curves were ﬁtted using Equation 2 and results of
ﬁts are shown in the Table 1.
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Parameters of agonist-stimulated [
35S]GTPgS binding to membranes from M2 CHO cells
pEC50
EMAX
[fold over basal] nH
Carbachol 4.91  0.04* 3.01  0.07 0.81  0.05
Furmethide 5.15  0.05 3.12  0.08 0.82  0.05
Oxotremorine 5.99  0.04** 2.78  0.06* 0.92  0.03
Pilocarpine 5.93  0.08** 1.59  0.06*** 0.98  0.03
Constants and Hill coefﬁcients (nH) were obtained by ﬁtting Equation 2 to data from individual experiments shown in Figure 1. Half-effective
molar concentration of agonists is expressed as negative logarithm (pEC50) and maximal stimulation (EMAX) as fold increase over basal binding.
Data are means  SEM of values from three individual experiments performed in quadruplicates. *P < 0.05, signiﬁcantly different from
furmethide; **P < 0.01, signiﬁcantly different from carbachol and furmethide; ***P < 0.001, signiﬁcantly different from all other agonists by
ANOVA and Tukey’s test.
CHO cells, Chinese hamster ovary cells; GTPgS, guanosine-5′-g-thiotriphosphate.
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Figure 2
Effects of guanine nucleotides on competition between agonists and [
3H]N-methylscopolamine (NMS) binding. Binding of 1 nM [
3H]NMS to
membranes in the presence of increasing concentrations (abscissa, log M) of the agonists carbachol (upper left), furmethide (upper right),
oxotremorine (lower left) and pilocarpine (lower right) is expressed as per cent of control binding in the absence of agonist. Data are shown for
binding to crude membranes (control); binding to crude membranes in the presence of 50 mM guanosine diphosphate (GDP); binding to crude
membranes in the presence of 1 mM guanosine-5′-g-thiotriphosphate (GTPgS); and binding to GDP-less membranes. Data are mean  SEM of
values from three experiments performed in quadruplicate. Curves were ﬁtted using Equations 3 and 4. Results of ﬁts are shown in the Table 2.
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and 4.6  0.6 pmol to Gs/olf G-proteins respectively (means 
SEM, n = 3).
Kinetics of [
35S]GTPgS binding to membranes
Measurements of 1 nM [
35S]GTPgS binding kinetics were
carried out on GDP-depleted membranes without (Figure 3,
left) or with added 50 mM GDP (Figure 3, right). As shown in
Table 3, addition of GDP slowed down the rate of association
3.2-fold, decreased equilibrium binding 4.7-fold, but did not
change the rate of dissociation (Figure 3, Table 3). A saturat-
ing concentration of carbachol (100 mM) did not change
kinetics of [
35S]GTPgS binding in the absence of GDP
(Figure 3, left, open circles). In the presence of GDP, carbachol
had no effect on the rate of dissociation of [
35S]GTPgS but
accelerated the rate of association 2.6-fold and increased
equilibrium binding fourfold (to 92 and 90% of that in the
absence of GDP respectively). In the presence of GDP, the
inverse agonist NMS slowed the association of [
35S]GTPgSb y
25% and, similarly to carbachol, did not change dissociation
kinetics (Table 3).
Kinetics of [
3H]GDP binding to membranes
Measurements of 500 nM [
3H]GDP binding kinetics (Figure 4)
were carried out on GDP-less membranes in the absence or in
the presence of 10 mMo r1 0 0mM carbachol or 0.1 mM NMS.
Association of [
3H]GDP was biphasic with an observed asso-
ciation rate (kobs slow) of 0.010 min
-1 for 44% of sites and kobs fast
of 0.063 min
-1 for the rest. Ten mM carbachol decelerated
association of the slower fraction sevenfold while it slowed
down that at the faster fraction by only twofold. Carbachol
(100 mM) brought further slowing down of both the slower
and faster fractions to 0.00024 min
-1 and 0.013 min
-1 respec-
tively. Dissociation of [
3H]GDP was also biphasic with disso-
ciationrateconstantskoff slow0.85 min
-1for40%ofsitesandkoff
fast 0.073 min
-1 for the rest. Carbachol accelerated [
3H]GDP
dissociation from the faster fraction more than 100-fold at
both concentrations while the rate at the slower fraction was
Table 2
Effects of guanine nucleotides on binding parameters of muscarinic agonists
Carbachol Furmethide Oxotremorine Pilocarpine
Control pKi high 6.92  0.08 7.12  0.09 7.93  0.07 7.19  0.08
pKil o w 5.04  0.08 4.78  0.08 6.24  0.07 5.65  0.08
flow [%] 59  11 50  96 6  85 8  9
+1 mM GTPgSp K i 5.13  0.05 4.76  0.05 6.26  0.04 5.54  0.06
+50 mM GDP pKi 5.19  0.06 4.77  0.05 6.38  0.04 5.67  0.05
GDP-less membranes pKi high 7.27  0.08* 7.77  0.08** 7.95  0.07 7.33  0.07
pKil o w 4.99  0.09 4.87  0.09 6.49  0.08 5.69  0.10
flow [%] 12  4** 9.6  3.8** 13  4** 7.9  3.2**
Equilibrium inhibition constants KI and percentages of low afﬁnity sites were obtained by ﬁtting Equations 3 and 4 to data from individual
experiments shown in Figure 2. KI values of agonists are expressed as negative logarithms of molar concentration (pKi). flow is the fraction of
receptors in the low-afﬁnity state. Data are means  SEM of values from three independent experiments performed in quadruplicates. *P <
0.05; **P < 0.01, signiﬁcantly different from corresponding control membranes by t-test.
GDP, guanosine diphosphate.
Table 3
Rate constants of [
35S]GTP-gS binding in GDP-less membranes
kobs [h-1]B eq [fmol·mg-1 protein] koff [h-1]
GDP-less membranes 4.35  0.15 5.66  0.22 0.324  0.013
+100 mM carbachol 4.33  0.17 5.70  0.25 0.327  0.014
50 mM GDP 1.34  0.14* 1.21  0.12* 0.334  0.012
+100 mM carbachol 3.98  0.14*
a 4.85  0.19*a 0.322  0.012
+100 nM NMS 1.01  0.08
a 1.20  0.11 0.343  0.009
Constants were obtained by ﬁtting Equations 5a or 6a as appropriate to data from individual experiments shown in Figure 3. kobs, association
rate constant; Beq, binding at equilibrium; koff, dissociation rate constant. Data are means  SEM of values from three independent
experiments performed in quadruplicates.*P < 0.01; signiﬁcantly different from control (GDP vs. GDP-less, with vs. without carbachol) and
aP < 0.05; signiﬁcantly different from control without ligand by t-test.
GDP, guanosine diphosphate; GTPgS, guanosine-5′-g-thiotriphosphate; NMS, N-methylscopolamine.
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respectively.
Allosteric interactions between GDP
and agonists
Carbachol-induced changes in GDP kinetics conﬁrmed allos-
teric interactions between GDP and carbachol. In order to
quantify allosteric interactions between GDP and agonists,
their afﬁnities to free receptor-G-protein complex had to be
known. Afﬁnity of GDP was determined in equilibrium
binding of [
3H]GDP to GDP-less membranes in homologous
competition (Figure 5 left) and saturation (Figure 5 right)
experiments. Homologous competition curves of 1 mM and
5 mM[
3H]GDP were monophasic with Hill coefﬁcient equal to
1 and IC50 values 4.48 (95% interval of conﬁdence 3.93–5.02)
and 8.55 (95% interval of conﬁdence 7.62–9.59) mM, respec-
tively, giving KD for [
3H]GDP of 3.49 mM. In accordance with
competition experiments, saturation binding of GDP-less
membranes with 0.3 to 10 mM[
3H]GDP displayed KD of 3.47
 0.03 mM and BMAX of 28  3 fmol of binding sites per mgo f
protein.
In the ﬁrst set of experiments to quantify the magnitude
of allosteric interactions between GDP and agonists, the
binding of [
3H]GDP at ﬁxed 10 mM concentration and
increasing concentrations of tested agonists was measured in
competition-like experiments (Figure 6). While the inverse
agonist NMS did not affect [
3H]GDP binding, all the tested
agonists decreased it. Fitting Eqn 7 to data using all four
agonists gave the same equilibrium dissociation constant for
[
3H]GDP (pKA 5.51  0.05; mean  SD; n = 12). Factors of
cooperativity a between binding of [
3H]GDP and carbachol,
furmethide, oxotremorine and pilocarpine were (expressed as
pa) -2.3  0.2, -2.4  0.3, -1.8  0.1 and -1.4  0.1 (mean
 SEM., n = 3) respectively.
In the second set of experiments determining the magni-
tude of allosteric interactions between GDP and agonists, we
employed [
3H]NMS as a tracer because of the high cost of
[
3H]GDP and difﬁculties in quantifying negative cooperativity
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Figure 3
Kinetics of [35S]guanosine-5′-g-thiotriphosphate (GTPgS) binding to membranes. Time course of association of 1 nM [35S]GTPgS with (top row) and
dissociation from (bottom row) GDP-less membranes. Binding was carried out either in the absence (left graphs) or presence (right graphs) of
50 mM GDP in the absence or presence of 100 mM carbachol or 100 nM N-methylscopolamine (NMS). Data are presented as mean  SEM of
values from three experiments performed in quadruplicate. Curves were ﬁtted using Equations 5 (association) or 6 (dissociation). Results of ﬁts
are shown in the Table 3.
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binding. The magnitude of negative cooperativity between
agonists and GDP in these experiments was derived from a
decrease in displacement of [
3H]NMS binding by a ﬁxed con-
centration of tested agonist by increasing concentrations of
GDP in GDP-less membranes. In the absence of agonist, GDP
had no effect on [
3H]NMS binding (Figure 7). Eqn 7 could not
be ﬁtted to the data and the factor of cooperativity a between
[
3H]NMS and GDP is thus equal to 1. Agonists competed with
[
3H]NMS and diminished its binding (Figure 7). GDP allosteri-
cally reduced the afﬁnity for agonists that was manifested as
an increase in [
3H]NMS binding. Factors of cooperativity b
between GDP and agonists were calculated by ﬁtting Eqn 8 to
the data shown in Figure 7. GDP diminished the afﬁnity of the
full agonists furmethide and carbachol 250-fold and 200-fold,
respectively, while the afﬁnity of the partial agonists
oxotremorine and pilocarpine was reduced only 60-fold and
25-fold respectively. Estimated afﬁnity for GDP was 3.2 mM
(pKA =- 5.49  0.03; mean  SEM.; n = 12) for all ﬁts.
Agonist stimulation of [
35S]GTPgS binding to
individual G-proteins
Binding of [
35S]GTPgS to individual subclasses of G-proteins
was measured in SPAs (Figure 8). As expected, all tested ago-
nists stimulated binding of [
35S]GTPgS to Gi/o G-proteins with
higher potency than to Gs/olf and Gq/11 G-proteins (Table 4).
The rank order of potencies was oxotremorine = pilocarpine >
furmethide > carbachol at all tested G-protein subclasses
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Figure 4
Kinetics of [3H]GDP binding to membranes. Time course of association 500 nM [3H]GDP with (left) and dissociation from (right) GDP-less
membranes in the absence or presence of 10 mM or 100 mM carbachol or 100 nM N-methylscopolamine (NMS). Data are expressed as mean 
SEM of values from three experiments performed in quadruplicate. Curves were ﬁtted using Equations 5 (association) or 6 (dissociation).
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Figure 5
Equilibrium binding of [3H]GDP to membranes. Left: Homologous competition of GDP (abscissa, log M concentration of GDP) with 1 mM and
5 mM[
3H]GDP binding (ordinate, percent of control binding). Right: [
3H]GDP saturation binding (abscissa, concentration in mM; ordinate,
[3H]GDP binding in fmol·mg-1 protein). Data are presented as mean  SEM of values from three experiments performed in quadruplicate. Curves
were ﬁtted using Equations 1 and 3 as appropriate.
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35S]GTPgS binding by oxotremo-
rine at Gq/11 was detected). Agonists were also more efﬁcacious
in stimulating [
35S]GTPgS binding at Gi/o G-proteins than at
the other two G-protein classes. The rank order of agonist
efﬁcacies to stimulate [
35S]GTPgS binding varied among
G-protein classes and was as follows: furmethide = carbachol
= oxotremorine > pilocarpine at Gi/o, carbachol = furmethide
> oxotremorine > pilocarpine at Gs/olf, and carbachol > furme-
thide > pilocarpine > oxotremorine at Gq/11.
Kinetics of [
3H]GDP binding to individual
subclasses of G-proteins
Kinetics of 500 nM [
3H]GDP binding at individual subclasses
of G-proteins measured in SPA is shown in Figure 9.
Association of [
3H]GDP with the Gi/o subclass of G-proteins
that preferentially couple with the M2 receptors was biphasic
(Figure 9, top left) with twice as many sites with fast (kobs1 =
0.055 min
-1) as with slow (kobs = 0.011 min
-1) association
kinetics (Table 5). Carbachol converted the association curve
to become monophasic and decreased equilibrium binding
1.8-fold and ninefold at 10 and 100 mM concentrations
respectively. Carbachol (100 mM) slowed down the associa-
tion of [
3H]GDP 12-fold in comparison to fast sites or 10-fold
in comparison to mono-exponential ﬁt of association data
under control conditions (in the absence of carbachol) (kobs =
0.042  0.005 min
-1;B eq = 2.8  0.3 fmol·mg·prot
-1; mean 
SEM; n = 3). Dissociation curves were biphasic in the absence
as well as in the presence of carbachol with 36 to 38% of slow
binding sites. Carbachol accelerated the dissociation rate to a
similar extent from both slow and fast sites. Acceleration was
6.3–6.5-fold by 10 mM carbachol and eightfold by 100 mM
carbachol respectively (Figure 9, lower left; Table 5).
Muscarinic M2 receptors also couple non-preferentially
with the Gs/olf and Gq/11 subclasses of G-proteins. We therefore
attempted to determine the inﬂuence of carbachol on the
kinetics of [
3H]GDP binding at these two other major
G-protein subclasses. Unlike the results obtained for the Gi/o
subclass, association and dissociation curves of [
3H]GDP
binding with Gs/olf were monophasic in the absence as well as
in the presence of carbachol (Figure 9, right column). Carba-
chol had no effect on [
3H]GDP binding association rate, accel-
erated [
3H]GDP dissociation rate 1.8-fold and threefold, and
decreased equilibrium binding 1.9-fold and 8.1-fold at 10 and
100 mM carbachol respectively (Figure 9, top right, Table 5).
We were not able to determine the kinetics of [
3H]GDP
binding at Gq/11 subclass of G-proteins due to extremely fast
on and off rates.
Allosteric interactions between GDP and
agonists at individual subclasses
of G-proteins
Effects of agonists on equilibrium binding of 10 mM[
3H]GDP
to individual subclasses of G-proteins was measured in SPA
(Figure 10, Table 6). All agonists decreased [
3H]GDP binding
to Gi/o (Figure 10, upper left) and Gs/olf (Figure 10, upper right)
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Figure 6
Direct measurement of allosteric interactions between agonists and
[3H]GDP at membranes. The magnitude of allosteric interactions
between agonists (carbachol, furmethide, oxotremorine, pilo-
carpine) or antagonist [N-methylscopolamine (NMS)] and GDP was
measured directly as changes in equilibrium binding of 10 mM
[
3H]GDP to GDP-less membranes in the presence of increasing ligand
concentration (abscissa, log M). Data are expressed as mean  SEM
of values from three experiments performed in quadruplicate. Curves
were ﬁtted using Equation 7.
Table 4
Parameters of [35S]GTPgS binding to Gi/o,G s/olf and Gq/11 subtypes of G-proteins
Gi/o Gs/olf Gq/11
pEC50 EMAX pEC50 EMAX pEC50 EMAX
carbachol 5.11  0.06 2.89  0.06 4.25  0.06 1.82  0.05 4.37  0.02 1.61  0.02
furmethide 5.34  0.10 2.95  0.09 4.76  0.03* 1.70  0.02 4.72  0.06* 1.20  0.01*
oxotremorine 6.03  0.05** 2.72  0.05 5.13  0.04** 1.53  0.01** n.c. n.c.***
pilocarpine 5.95  0.06** 1.52  0.05*** 5.05  0.05** 1.10  0.01*** 4.95  0.05** 1.08  0.01***
Constants and Hill coefﬁcients (nH) were obtained by ﬁtting Equation 2 to data from individual experiments shown in Figure 1. Half effective
molar concentration of agonists is expressed as negative logarithm (pEC50) and maximal stimulation (EMAX) as fold increase over basal binding.
Data are means  SEM of values from three individual experiments performed in quadruplicates. *P < 0.05, signiﬁcantly different from
carbachol; **P < 0.01, signiﬁcantly different from carbachol and furmethide; ***P < 0.001, signiﬁcantly different from all other agonists by
ANOVA and Tukey’s test.
GTPgS, guanosine-5′-g-thiotriphosphate; n.c., no convergence.
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nists, had no effect on [
3H]GDP equilibrium binding to Gq/11
(Figure 10, lower panel) G-proteins. The rank order of factors
of cooperativity between [
3H]GDP and agonist binding varied
among G-protein classes and was as follows: furmethide =
carbachol = oxotremorine > pilocarpine at Gi/o, carbachol =
furmethide > oxotremorine > pilocarpine at Gs/olf, and carba-
chol > furmethide > pilocarpine > oxotremorine at Gq/11
(Table 6).
Discussion
Conventional determination of agonist efﬁcacy of G-protein
coupled receptors often utilizes measurements of agonist-
induced activation of GTPgS binding. We analysed the role of
GDP (the second guanine nucleotide that binds to
G-proteins) in the process of activation of the M2 muscarinic
acetylcholine receptors and tested whether changes in its
binding could serve as a possible measure of agonist efﬁcacy.
The muscarinic agonists studied here differ in structure as
well as afﬁnity and efﬁcacy to stimulate GTPgS binding via
the M2 muscarinic receptor (Figure 1). Binding studies show
that GTPgS decreases the afﬁnity of agonists as reported pre-
viously for the majority of, if not all, GPCRs (Wess, 1997). The
decrease in agonist afﬁnity is generally interpreted as being
due to disintegration of the receptor/G-protein complex and
the liberation of the signalling GTPgS-liganded G-protein
a-subunit and complex of bg subunits (Johnston and Sid-
erovski, 2007). In accordance with previous ﬁndings (Haga
et al., 1986; Florio and Sternweis, 1989; Tota and Schimerlik,
1990; Shiozaki and Haga, 1992) our data demonstrate that at
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Indirect measurement of allosteric interactions between agonists and GDP at membranes. The magnitude of allosteric interactions between
agonists (carbachol, upper left; furmethide, upper right; oxotremorine, lower left; pilocarpine, lower right) and GDP was measured indirectly as
changes in equilibrium binding of 1 nM [3H]N-methylscopolamine (NMS) to GDP-less membranes in the presence of a ﬁxed concentration of
agonist and increasing concentrations of GDP (abscissa, log M). Binding of 1 nM [
3H]NMS in the absence of agonis is also shown (control).
Carbachol and furmethide were used at 3 and 10 mM, oxotremorine at 0.1 and 0.3 mM, and pilocarpine at 0.3 and 1 mM. Data are presented as
mean  SEM of values from three experiments performed in quadruplicate. Curves were ﬁtted using Equations 7 ([
3H]NMS alone) or 8 ([3H]NMS
in the presence of agonist).
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1038 British Journal of Pharmacology (2011) 162 1029–1044the muscarinic M2 receptors GDP also decreases agonist afﬁn-
ity. In addition, we found that reduction of membrane-bound
GDP increases the proportion of high-afﬁnity binding sites
for all agonists to a similar extent (Figure 2). Adding GDP
back to GDP-less membranes reduces agonist afﬁnity
(Figure 7). These ﬁndings are consistent with the existence of
an agonist low-afﬁnity conformation of the receptor that
is complexed with GDP-liganded G-protein, in addition to
the agonist low-afﬁnity conformation of receptor that is
uncoupled from G-protein upon binding of GTP (Abdulaev
et al., 2006).
Although the afﬁnity of agonists at the low-afﬁnity
binding state is similar in the presence of either GDP or
GTPgS, kinetics of guanine nucleotides binding provide evi-
dence that the molecular mechanisms of modulation of
agonist afﬁnity is different. The ability of carbachol to
accelerate dissociation and decelerate association of GDP
(Figure 4) proves the existence of allosteric interaction
between agonist and GDP on the receptor/G-protein
complex. On the other hand, the inability of agonists to
change the kinetics of GTPgS binding in the absence of GDP
(Figure 3, left column; Table 3) is in concert with data
obtained in a reconstituted system (Florio and Sternweis,
1989) and the commonly accepted concept that the GTPgS-
liganded Ga subunit dissociates from receptor (Johnston and
Siderovski, 2007) and therefore the kinetics of GTPgS binding
cannot be allosterically regulated by agonists. Receptor-
mediated acceleration of GTPgS association in the presence of
GDP (Figure 3, upper row; Table 3) is a consequence of accel-
erated GDP dissociation, while in the absence of GDP the
speed of GTPgS binding (irrespective of presence or absence of
agonist) is already maximal. Lack of effect of agonists on the
rate of GTPgS dissociation in both the presence and absence
of GDP (Figure 3, lower row; Table 3) further supports the
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Figure 8
Stimulation of [35S]guanosine-5′-g-thiotriphosphate (GTPgS) binding to Gi/o,G s/olf and Gq/11 G-proteins by agonists. [35S]GTPgS binding to Gi/o
(upper left), Gs/olf (upper right), and Gq/11 (lower row) G-proteins stimulated by increasing concentrations (abscissa, log M) of agonists carbachol,
furmethide oxotremorine and pilocarpine or antagonist N-methylscopolamine (NMS) is expressed as fold over basal (ordinate). Data are presented
as mean  SEM of values from three experiments performed in quadruplicate. Curves were ﬁtted using Equation 2 and results of ﬁts are shown
in the Table 4.
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subunit with bound GTPgS is not in physical contact with the
receptor.
Agonist-induced allosteric acceleration of GDP dissocia-
tion from the Ga subunit strongly implies involvement of
this mechanism in regulating the strength (efﬁcacy) of
agonist signal transmission to intracellular second messen-
ger pathways. Despite multiple lines of evidence for allos-
teric interaction between agonist and GDP on receptor-G-
protein complex the magnitude of these allosteric
interactions has not been quantiﬁed so far. Our present data
show that the magnitude of negative cooperativity between
the four tested agonists displaying different potencies and
efﬁcacies, and GDP binding (Figure 6) demonstrate that
full agonists (carbachol, furmethide) display signiﬁcantly
stronger negative cooperativity than partial agonists
(oxotremorine, pilocarpine). The magnitude of negative
cooperativity correlates with agonist efﬁcacy in stimulating
GTPgS binding to membranes (furmethide  carbachol >
oxotremorine > pilocarpine) (Figure 11). Interestingly, 30
years ago Birdsall et al. (1978) showed that agonist efﬁcacy
correlates with the ratio of agonist high- and low-afﬁnity
binding. Our results conﬁrm these observations and provide
a plausible interpretation. Agonist high-afﬁnity binding
takes place at a receptor-G-protein complex free of GDP and
low-afﬁnity binding occurs at a complex with GDP-liganded
G-protein that is low due to negative cooperativity in
binding of agonist and GDP. The stronger the negative
cooperativity (more negative pa in our experiments) is, the
higher the agonist efﬁcacy and the lower the agonist afﬁnity
is in the low-afﬁnity binding state. Thus, agonist efﬁcacy
correlates with the difference in afﬁnities of the agonist
high and low-afﬁnity binding states.
In addition to inhibition of adenylyl cyclase (Gi-
mediated), activation of non-preferential G-proteins is asso-
ciated with strong stimulation of adenylyl cyclase and
Table 5
Effects of carbachol on the kinetics of [
3H]GDP binding to Gi/o and Gs/olf G-proteins
Control 10 mM carbachol 100 mM carbachol
Gi/o kobs1 [min-1] 0.055  0.003 0.0056  0.0003** 0.0044  0.0002**
Beq1 [fmol·mg
-1 protein] 2.1  0.2 1.7  0.2** 0.35  0.03**
kobs2 [min
-1] 0.011  0.006
Beq2 [fmol·mg-1 protein] 1.1  0.1
koff1 [min
-1] 0.35  0.03 2.2  0.2** 2.8  0.3**
koff2 [min
-1] 0.040  0.004 0.26  0.03** 0.32  0.03**
f2 [%] 37  53 8  43 6  5
Gs/olf kobs [min
-1] 0.031  0.003 0.030  0.003 0.031  0.003
Beq [fmol·mg
-1 protein] 0.81  0.04 0.43  0.02** 0.10  0.01**
koff [min
-1] 0.067  0.007 0.12  0.01** 0.20  0.02**
Association rate constants (kobs), equilibrium binding (Beq), dissociation rate constants (koff) and percentages (f2) of populations were obtained
by ﬁtting Equations 6a and 6b or 7a and 7b as appropriate to data from individual experiments shown in Figure 9. Values from better ﬁts are
shown. Data are means  SEM of values from three independent experiments performed in triplicates. **P < 0.01, signiﬁcantly different from
control in the absence of carbachol by t-test.
GDP, guanosine diphosphate.
Table 6
Parameters of [3H]GDP binding to Gi/o,G s/olf and Gq/11 subtypes of G-proteins
Gi/o Gs/olf Gq/11
pKA pa pKA pa pKA pa
Carbachol 6.90  0.06 -2.3  0.2 6.87  0.06 -1.2  0.1 6.87  0.02 -0.85  0.09
Furmethide 7.13  0.05 -2.4  0.2 7.10  0.05 -1.0  0.1 7.17  0.06 -0.32  0.05
Oxotremorine 7.93  0.05 -2.1  0.2 7.97  0.05 -0.78  0.08 n.c. n.c.
Pilocarpine 7.23  0.06 -0.94  0.08 7.19  0.07 -0.24  0.04 7.25  0.08 -0.16  0.03
Equilibrium dissociation constants (KA) of agonists and factors of cooperativity (a) between agonists and [
3H]]GDP binding are expressed as
negative logarithms. Constants were obtained by ﬁtting Equation 7 to data from individual experiments shown in Figure 10. Data are means
 SEM of values from three independent experiments performed in quadruplicates.
GDP, guanosine diphosphate.
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phates (Gq-medited) by muscarinic M2 receptors was
observed repeatedly (Ashkenazi et al., 1987; Burford et al.,
1995; Jakubík et al., 1996; Michal et al., 2001; 2007). In
SPAs, furmethide, carbachol and pilocarpine stimulated
GTPgS binding to preferential Gi/o as well as non-preferential
Gs/olf and Gq/11 G-proteins. In contrast, oxotremorine stimu-
lated GTPgS binding only to Gi/o and Gs/olf G-proteins
(Figure 8, Table 4). Different orders of efﬁcacies at individual
G-protein classes can be explained by the concept of
agonist speciﬁc conformations (Kenakin, 2003), where indi-
vidual agonists induce different receptor conformations that
differ in the ability to activate individual classes of
G-proteins.
In agreement with an allosteric mode of action, afﬁnities
of GDP for the Ga subunits calculated from interactions with
all of the tested agonists are the same (between 2.9 and
3.4 mM; Figures 6, 7 and 10) and correspond well to published
values (Thomas et al., 1993) as well as results of [
3H]GDP
kinetics (Figures 4 and 9; Tables 3 and 5) and [
3H]GDP satu-
ration binding (Figure 5). Thus, changes in GDP afﬁnity or
kinetics are good measures of agonist efﬁcacy at the Gi/o-
coupled M2 muscarinic receptor. In practice, being the ﬁrst
step next to receptor activation, [
3H]GDP binding appears to
be a more direct measure of receptor activation than GTPgS
binding or second messenger levels in case of M2 receptors,
and this may be so at other Gi/o coupled GPCRs. However, this
assay requires laborious preparation of membranes free of
GDP. Agonist induced changes in GTPgS binding were dem-
onstrated in fused Gsa/b2-adrenoceptors where agonist efﬁ-
cacy was well reﬂected by changes in the kinetics of GTPgS
binding (Wenzel-Seifert and Seifert, 2000; Seifert et al., 2001).
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Figure 9
Kinetics of [
3H]GDP binding to Gi/o and Gs/olf G-proteins. Association of 500 nM [
3H]GDP with Gi/o (top left) and Gs/olf (top right) and dissociation
of 500 nM [
3H]GDP from Gi/o (bottom left) and Gs/olf (bottom right) subclasses of G-proteins was measured by scintillation proximity assay as
described in Methods. GDP-less membranes were pre-incubated for 20 min with either buffer or 10 mMo r1 0 0mM carbachol. Then, 500 nM
[
3H]GDP was added and association terminated by ﬁltration at the indicated times (abscissa, min). [3H]GDP binding (ordinate) is expressed as fmol
per mg of protein. In dissociation measurements, GDP-less membranes were equilibrated for two hours in the presence of 500 nM [
3H]GDP.
Dissociation was then initiated by the addition of 50 mM GDP alone or in combination with carbachol at 10 mM or 100 mM and terminated at
indicated times (abscissa, min). [
3H]GDP binding (ordinate) is expressed as per cent of binding at the beginning of dissociation. Data are expressed
as mean  SEM of values from three experiments performed in triplicate. Curves were ﬁtted using Equations 5a and 5b (association) or 6a and
6b (dissociation). Results of ﬁts are shown in Table 5.
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induced decrease in GDP afﬁnity in G-protein activation,
GDP differentially and concentration-dependently inﬂu-
enced relative efﬁcacies of partial agonists in increasing
GTPgS binding (Wenzel-Seifert and Seifert, 2000). In accor-
dance with previous ﬁndings (Florio and Sternweis, 1989),
agonists at M2 receptors under our experimental conditions
do not change the kinetics of GTPgS binding in the absence of
GDP (Figure 3). Thus, while a change in the kinetic of GTPgS
binding is a good measure of activation of physically coupled
G-protein/b2- adrenoceptors, kinetics of GDP binding seem to
be a closer measure in case of M2 muscarinic receptors and
likely in other GPCR. Another drawback of GTPgS binding
measurements is their dependence on the concentration of
GDP that strongly affects outcome of the experiments
(Figure 3). Also, unlike GDP binding, GTPgS concentration–
response curve has to be measured under non-equilibrium
conditions (Figure 3).
The data presented here show some interesting aspects of
the process of receptor activation. NMS was reported as an
inverse agonist at the M2 receptor (Jakubík et al., 1995; Burst-
ein et al., 1997) and behaved as inverse agonist under our
experimental conditions (Figures 1 and 8). Although positive
cooperativity in binding with GDP would be expected, our
data show that the cooperativity between NMS and GDP is
neutral (Figures 6 and 7) and NMS only slightly slows down
GDP dissociation (Figure 4 right), implying different mecha-
nisms underlying the inverse agonist nature of NMS. One
possible explanation may be that NMS stabilizes the receptor
in the ground state (inactive conformation) (Hulme et al.,
2003) that leads to reduction of spontaneous transition of the
ligand-free receptor to an active state and slower rate of GDP
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Figure 10
Allosteric interactions between agonists and [3H]GDP at individual G-proteins. The magnitude of allosteric interactions between agonists
(carbachol, furmethide, oxotremorine, pilocarpine) and [
3H]GDP was measured directly as changes in equilibrium binding of 10 mM[
3H]GDP to
Gi/o (upper left), Gs/olf (upper right) or Gq/11 (lower row) G-proteins in the presence of increasing ligand concentration (abscissa, log M) via
scintillation proximity assay as described in Methods. Data are presented as mean  SEM of values from three experiments performed in
quadruplicate. Curves were ﬁtted using Equation 7. Results of ﬁts are shown in the Table 6.
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agonism and inverse agonism cannot be revealed by measure-
ment of GTPgS binding.
The second interesting aspect of our study is derived from
data shown in Figure 9 that illustrates that carbachol slows
down association of GDP with Gi/o G-proteins but does not
change the rate of association of GDP with Gs/olf G-proteins.
These data suggest that interaction of the M2 receptor with
preferential Gi/o G-proteins differs from that with non-
preferential Gs/olf G-proteins. One possible explanation is that
Gi/o G-proteins precouple to M2 receptors while Gs/olf do not
(Shea and Linderman, 1997; Hein et al., 2005), where precou-
pling gives an agonist a chance to inﬂuence GDP association
while collision coupling does not. However, demonstration
of this difference in coupling requires further detailed analy-
sis. Again, this difference in kinetics at Gi/o and Gs/olf classes of
G-proteins cannot be revealed by measurement of GTPgS
binding.
In conclusion, we have demonstrated that the negative
cooperativity between GDP and agonist binding played a
key role in signal transduction via the M2 receptor. Agonist-
induced low-afﬁnity conformation of the Ga G-protein
subunit for GDP leads to accelerated dissociation of bound
GDP that in turn accelerates binding of GTP and G-protein
activation. Thus, stronger negative cooperativity between a
given agonist and GDP binding leads to a bigger shift of the
GDP/GTP afﬁnity ratio resulting in a higher rate of GTP
binding and agonist efﬁcacy. Our data demonstrated ben-
eﬁts of GDP binding measurements that can reveal mecha-
nistic differences that are not apparent in measurements of
GTP binding, as was demonstrated in case of inverse ago-
nists versus agonists or Gi/o versus Gs/olf G-proteins. Measure-
ments of GDP binding therefore provide additional
information beyond that obtained from GTP binding mea-
surements.
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